Which Patients Show the Least Benefit from the RSV Vaccine? Key Insights Revealed
Immunocompromised Patients May Need Stronger RSV Vaccine Protection, Study Finds A new study reveals that immunocompromised patients, including those with chronic diseases or weakened immune systems, may not produce sufficient protective antibodies after receiving the vaccine against respiratory syncytial virus (RSV). Researchers from Johns Hopkins University emphasize the need for further examination to enhance immune … Read more